VALIDATION OF SURROGATE ENDPOINTS IN ADVANCED SOLID TUMORS: SYSTEMATIC REVIEW OF STATISTICAL METHODS, RESULTS, AND IMPLICATIONS FOR POLICY MAKERS
出版年份 2014 全文链接
标题
VALIDATION OF SURROGATE ENDPOINTS IN ADVANCED SOLID TUMORS: SYSTEMATIC REVIEW OF STATISTICAL METHODS, RESULTS, AND IMPLICATIONS FOR POLICY MAKERS
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
Volume 30, Issue 03, Pages 312-324
出版商
Cambridge University Press (CUP)
发表日期
2014-09-02
DOI
10.1017/s0266462314000300
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study
- (2013) O. Ciani et al. BMJ-British Medical Journal
- Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)
- (2012) Marissa N Lassere et al. BMC Medical Research Methodology
- Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma
- (2012) T E Delea et al. BRITISH JOURNAL OF CANCER
- Postprogression Survival in Patients With Advanced Non–Small-Cell Lung Cancer Who Receive Second-Line or Third-Line Chemotherapy
- (2012) Hidetoshi Hayashi et al. Clinical Lung Cancer
- Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
- (2012) Xiaoqin Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Biomarkers as Surrogate Endpoints in Cancer Trials
- (2012) Barbara K. Dunn et al. Seminars in Oncology Nursing
- Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points
- (2011) L. Lee et al. ANNALS OF ONCOLOGY
- Poor correlation between progression-free and overall survival in modern clinical trials: Are composite endpoints the answer?
- (2011) Eitan Amir et al. EUROPEAN JOURNAL OF CANCER
- Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
- (2011) T. Berghmans et al. EUROPEAN RESPIRATORY JOURNAL
- A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer
- (2011) Sudha Sundar et al. GYNECOLOGIC ONCOLOGY
- Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
- (2011) Costel Chirila et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Estimating changes in overall survival using progression-free survival in metastatic breast and colorectal cancer
- (2011) Russell J. Bowater et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials
- (2011) Kohei Shitara et al. INVESTIGATIONAL NEW DRUGS
- Survival Is Not a Good Outcome for Randomized Trials With Effective Subsequent Therapies
- (2011) Marc Buyse et al. JOURNAL OF CLINICAL ONCOLOGY
- Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
- (2011) M.-Y. C. Polley et al. NEURO-ONCOLOGY
- Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review
- (2011) Katsuyuki Hotta et al. PLoS One
- Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy
- (2010) Daniel Y. C. Heng et al. CANCER
- Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer
- (2010) Nathan R. Foster et al. CANCER
- Use of Meta-Analysis for the Validation of Surrogate Endpoints and Biomarkers in Cancer Trials
- (2010) Marc Buyse CANCER JOURNAL
- Progression-Free Survival Is Simply a Measure of a Drug’s Effect While Administered and Is Not a Surrogate for Overall Survival
- (2010) Julia Wilkerson et al. CANCER JOURNAL
- Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: A Gynecologic Oncology Group study
- (2010) Peter G. Rose et al. GYNECOLOGIC ONCOLOGY
- Overall Survival and Post-Progression Survival in Advanced Breast Cancer: A Review of Recent Randomized Clinical Trials
- (2010) Everardo D. Saad et al. JOURNAL OF CLINICAL ONCOLOGY
- Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007
- (2010) R. Sridhara et al. JNCI-Journal of the National Cancer Institute
- Time to Progression as a Surrogate Marker for Overall Survival in Patients with Advanced Non-small Cell Lung Cancer
- (2010) Katsuyuki Hotta et al. Journal of Thoracic Oncology
- Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer
- (2010) Sumithra J. Mandrekar et al. Journal of Thoracic Oncology
- Biomarkers and surrogate end points—the challenge of statistical validation
- (2010) Marc Buyse et al. Nature Reviews Clinical Oncology
- Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature
- (2009) E. D. Saad et al. ANNALS OF ONCOLOGY
- Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials
- (2009) Qian Shi et al. International Journal of Clinical Oncology
- Use of surrogate outcomes in cost-effectiveness models: A review of United Kingdom health technology assessment reports
- (2009) Julian Elston et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Surrogate outcomes in health technology assessment: An international comparison
- (2009) Marcial Velasco Garrido et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer
- (2009) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer
- (2008) B Sherrill et al. BRITISH JOURNAL OF CANCER
- The relationship between progression-free and post-progression survival in treating four types of metastatic cancer
- (2008) Russell J. Bowater et al. CANCER LETTERS
- Recommendations for the assessment of progression in randomised cancer treatment trials
- (2008) J.E. Dancey et al. EUROPEAN JOURNAL OF CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Progression-free survival as a surrogate endpoint in advanced breast cancer
- (2008) Rebecca A. Miksad et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer
- (2008) Tomasz Burzykowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Surrogate endpoint validation: statistical elegance versus clinical relevance
- (2008) EM Green et al. STATISTICAL METHODS IN MEDICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More